Brolucizumab for the Treatment of Diabetic Macular Edema: An Optical Coherence Tomography-Based Analysis
<b>Objectives</b>: The objectives of this study were to evaluate the structural and functional outcomes after the loading phase with brolucizumab in switched patients with diabetic macular edema (DME) and to identify potential predictive biomarkers of treatment response. <b>Methods...
Saved in:
Main Authors: | Marco R. Pastore, Serena Milan, Stefano Gouigoux, Olimpia Colombo, Silvia Rinaldi, Gabriella Cirigliano, Daniele Tognetto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/14/24/2858 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multifocal electroretinogram evaluation of different optical coherence tomography patterns of diabetic macular edema
by: Abdelrahman W.M. Mohamed, et al.
Published: (2025-01-01) -
Comparison of the effect of ranibizumab in retinal vein occlusion and macular edema with different optical coherence tomographic patterns
by: Yue Xu, et al.
Published: (2025-02-01) -
Diagnostic markers of severe diabetic macular edema in patients with type 2 diabetes
by: S.A. Suk, et al.
Published: (2024-12-01) -
Early response of anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) management: microperimetry and optical coherence tomography (OCT) findings: a pilot study at national eye center of third world country
by: Grimaldi Ihsan, et al.
Published: (2024-12-01) -
Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema
by: Sanjay Kumar Mishra, et al.
Published: (2025-01-01)